Recruiting
Phase 2

Hyperpolarized 13C-Pyruvate

Sponsor:

Robert Bok, MD, PhD

Code:

NCT06391034

Conditions

Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

hyperpolarized pyruvate +/-urea (13C/15N)

Non-investigational External beam radiotherapy (EBRT)

Radiotherapy (RT)

Multi-parametric magnetic resonance imaging (mpMRI)

Non-interventional hormone therapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-18. This information was provided to ClinicalTrials.gov by Robert Bok, MD, PhD on 2026-01-07.